Also, restoration of HEVM ectodomain by soluble HVEM protein or HVEM-producing and CD19-targeted CAR-T cells were tumor-suppressive in MYC + /BCL2 + DLBCL cell lines and BCL2 overexpressing lymphoma xenograft model, respectively [134]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.